Shots: Medigene to receive $10M upfront, $1B as development, regulatory, and commercial milestones & royalties on sales of four products in multiple indications. Cytovant to get exclusive development & commercialization […]readmore
Tags : Collaborates
Shots: EspeRare to get EU development rights of DMX-101, developed under the name ER-004. Dermelix to get WW development & exclusive commercialization rights for EspeRare’s DMX-101 (Ex- Europe) In H2’19 […]readmore
Shots: Mitsubishi Tanabe Pharma (MTPA) enters into a collaboration with Massachusetts General Hospital (MGH) Neurological Clinical Research Institute (NCRI) to conduct ALS biomarker study for identification of biomarkers in patients […]readmore
Biotech
Pharma
Takeda Collaborates with LegoChem Biosciences (LCB) to Develop Antibody-Drug Conjugates
Shots: LCB to receive $7.25M upfront, $404M as regulatory & commercial milestones and royalties on sales of ADCs product. Takeda licenses rights for LCB’s ConjuAll technology including linker and conjugation […]readmore
Shots: Celgene & Exscientia enter into a 3yrs. partnership to accelerate the development of small molecules for three therapeutic programs for Celgene using Exscientia’s Centaur Chemist AI drug discovery platform […]readmore
Shots: Evotec and GARDP enter into an agreement to develop novel therapies for growing threat of antimicrobial resistance (AMR) The focus of the collaboration is to combine GARDP’s clinical expertise […]readmore
Shots: Merck KGaA & GenScript enter into a collaboration agreement to accelerate the industrialization and commercialization of cell and gene therapy in China. Merck to provide products, services & staff […]readmore
Shots: Baxter and BioMerieux enter into an agreement to develop biomarkers for identification & treatment for acute kidney injury (AKI) The focus of the agreement is to utilize BioMerieux’s expertise […]readmore
Shots: Merck KGaA enters into an agreement with Iktos to develop therapies using Iktos’ AI technology for three drug discovery projects The focus of the agreement is to develop and […]readmore
Shots: AdoRx enters into a collaboration with J&J’s Lung Cancer Initiative & J&J Innovations for drug discovery and preclinical candidates. J&J to get an exclusive option to research, develop, and […]readmore